A phase IIIb study of 8-week glecaprevir/pibrentasvir treatment in adults with acute hepatitis C. Llibre JM, Boesecke C, Moon J, Lank PM, et al. J Hepatol 2025 Nov 24:S0168-8278(25)02625-X. doi: 10.1016/j.jhep.2025.

Read + Share

Amedeo Smart

Independent Medical Education

Llibre JM, Boesecke C, Moon J, Lank PM, et al. A phase IIIb study of 8-week glecaprevir/pibrentasvir treatment in adults with acute hepatitis C. J Hepatol 2025 Nov 24:S0168-8278(25)02625-X. doi: 10.1016/j.jhep.2025.
PMID: 41297677